ANDROSTAN-3-ONE, 17-(ACETYLOXY)-2-FLUORO-, (2.ALPHA.,5.ALPHA.,17.BETA.)-
UNII VAP1HL22AB
Substance Identification & Data
This profile provides standardized clinical and technical data for Androstan-3-one, 17-(acetyloxy)-2-fluoro-, (2.alpha.,5.alpha.,17.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VAP1HL22AB.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1648-61-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H31FO3 WACIVNIHJKQSFP-LKIOEXHTSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Androstan-3-one, 17-(acetyloxy)-2-fluoro-, (2.alpha.,5.alpha.,17.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.